Number of Vets being referred to private doctors is rising, VA secretary says
Robert McDonald tells American Veterans national convention that his department is quickly moving to significantly increase the number of veterans referred to doctors outside the system. Also, the...
View ArticleALS Association surpasses $10 million in "Ice Bucket" donations
Today, The ALS Association announced it has surpassed $10 million in "Ice Bucket" donations. Specifically, as of Saturday, August 16, 2014, The ALS Association has received $11.4 million in donations...
View ArticleFirst Edition: August 28, 2014
Today's headlines include reports about the Congressional Budget Office's latest projections regarding Medicare and Medicaid spending.
View ArticleNew approach to turn diseased cells into unique manufacturing sites for...
In a new study that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have adapted a chemical approach to turn diseased cells into...
View ArticleSix research institutions awarded NIH grants to create database of human...
Building on a successful three-year pilot project, the National Institutes of Health has awarded more than $64 million to six research institutions to create a database of human cellular responses, the...
View ArticleNew study sheds light on longstanding question about role of mitochondria in...
A new study by researchers at the University of Utah School of Medicine sheds light on a longstanding question about the role of mitochondria in debilitating and fatal motor neuron diseases and...
View ArticleNorthwestern scientists develop first animal model for ALS dementia
The first animal model for ALS dementia, a form of ALS that also damages the brain, has been developed by Northwestern Medicine- scientists. The advance will allow researchers to directly see the...
View ArticleCedars-Sinai to participate in a consortium studying motor neuron disorders
Investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute have received a grant from the National Institutes of Health to participate in a consortium taking the study of...
View ArticleFDA designates NurOwn as Fast Track product for ALS treatment
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the United States Food and Drug Administration (FDA) has...
View ArticleUCI to receive $8 million from NIH to study brain cell activity in motor...
UC Irvine will receive $8 million from the National Institutes of Health to establish one of six national centers dedicated to creating a database of human cellular responses that will accelerate...
View ArticleProteins linked to severe forms of ALS are less stable, suggests new study
A new study by scientists from The Scripps Research Institute, Lawrence Berkeley National Laboratory and other institutions suggests a cause of amyotrophic lateral sclerosis (ALS), also known as Lou...
View ArticleScientists use innovative exome sequencing strategy to identify new gene...
Using an innovative exome sequencing strategy, a team of international scientists led by John Landers, PhD, at the University of Massachusetts Medical School has shown that TUBA4A, the gene encoding...
View ArticleUC San Diego Sanford Stem Cell Clinical Center named new 'alpha clinic'
In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new "alpha clinics" by the...
View ArticleDigoxin drug may be adaptable for ALS treatment, study suggests
Digoxin, a medication used in the treatment of heart failure, may be adaptable for the treatment of amyotrophic lateral sclerosis (ALS), a progressive, paralyzing disease, suggests new research at...
View ArticleAging astrocytes lose ability to protect motor neurons, reveal Cedars-Sinai...
Lou Gehrig's disease, also known as amyotrophic lateral sclerosis, or ALS, attacks muscle-controlling nerve cells – motor neurons – in the brain, brainstem and spinal cord, leading to progressive...
View ArticleResearch paves way for improving efficacy of ALS treatement
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that primarily kills motor neurons, leading to paralysis and death 2 to 5 years from diagnosis....
View ArticleCedars-Sinai Medical Center releases November tip sheet of story ideas
Following is the November 2014 tip sheet of story ideas from Cedars-Sinai Medical Center.
View ArticleResearchers remake brain and gut stem cells to study potential therapies for...
Research scientists have developed a novel method to re-create brain and intestinal stem cells from patients who died decades ago, using DNA from stored blood samples to study the potential causes of...
View ArticleGenetics may play major role in Lou Gehrig's disease, study reveals
Genetics may play a larger role in causing Lou Gehrig's disease than previously believed, potentially accounting for more than one-third of all cases, according to one of the most comprehensive genetic...
View ArticleResearchers reveal that genetic mutations may cause more cases of ALS
Genetic mutations may cause more cases of amyotrophic lateral sclerosis (ALS) than scientists previously had realized, according to researchers at Washington University School of Medicine in St. Louis...
View Article
